Pharma Industry Infonugget #5 - How often did companies review their CMO contracts?

Add bookmark

Pharma Industry Infonugget 5

 

How often did companies review their CMO contracts?

To see if this trend has continued please visit PharmaIQ

 

55.6% review contracts every 6 months

33.3% say they review their contracts annually

11.1% leave contracts in place for 2-3 years without review

 

For other statistics and further pharma business trends, attend our conferences.


Latest Webinars

Pharma IQ's Power List 2022: In conversation with pharma's top leaders

2022-10-18

02:00 PM - 03:00 PM BST

Join us to hear from the most influential people in pharma today, as voted for by you

A post-pandemic 3D view of the patient and supply journey

2022-06-01

04:30 PM - 05:30 PM CET

In this panel discussion with experts from 4G Clinical, THREAD Research and World Courier, learn how...

Discover how targeted radiotherapy induced toxicity can be identified with imaging

2022-04-28

01:00 PM - 02:00 PM EST

This Pharma IQ webinar with AIQ explores how AI-assisted analysis of radiological scans enhances the...

Recommended